Severe viral illness tied to later lung cancer risk

Severe infections caused by COVID-19 or influenza may raise the likelihood of developing lung cancer years later, according to new scientific findings that highlight the long-term consequences of major respiratory disease. Researchers report that serious viral illness can leave persistent changes in the lungs, creating conditions that may allow tumours to form long after the original infection has cleared.

Scientists studying the biological aftermath of respiratory viruses found that severe infections appear to reprogramme immune cells within lung tissue. These altered cells can trigger chronic inflammation and disrupt the normal mechanisms that prevent abnormal cells from multiplying. Over time, that environment may allow dormant or damaged cells to grow into malignant tumours.

The findings centre on cases where viral illness is severe enough to require hospital treatment. Researchers observed that patients recovering from such infections often show signs of long-lasting immune activity in the lungs. This sustained inflammatory state, which may continue for months or even years, is thought to contribute to the increased cancer risk identified in the study.

Investigators analysing lung tissue and immune responses discovered that certain immune cells remain activated well after the virus has disappeared. Instead of returning to their typical protective roles, these cells can produce inflammatory signals that alter the tissue environment. Such persistent inflammation has long been recognised as a factor in the development of several types of cancer, including tumours in the lungs.

Laboratory experiments and animal studies indicate that severe viral infections may leave behind microscopic tissue damage and changes to immune signalling pathways. These effects appear to weaken the lung’s ability to eliminate abnormal cells, which normally would be destroyed before they develop into cancer. When that surveillance system becomes disrupted, the likelihood of tumour formation can increase.

Scientists emphasise that the elevated risk is associated primarily with serious illness. Mild infections, including those that do not require hospital care, show far weaker evidence of causing lasting lung damage. The distinction underscores the importance of understanding how the severity of respiratory disease influences long-term health outcomes.

The research builds on a broader body of evidence linking chronic inflammation with cancer development. Persistent inflammation can encourage genetic mutations, stimulate cell growth and promote the formation of blood vessels that nourish tumours. In the lungs, repeated injury or prolonged immune activation may therefore create conditions favourable for cancer progression.

Public health experts note that respiratory viruses have historically been associated with complex long-term consequences. Earlier studies have suggested links between certain infections and cancers in other organs, though the mechanisms differ depending on the virus and tissue involved. The emerging evidence around severe respiratory illness adds another dimension to understanding how infections can shape disease risk over time.

Vaccination appears to play an important role in reducing the harmful lung changes associated with these infections. Scientists involved in the research observed that vaccinated individuals were less likely to experience the persistent inflammatory patterns seen in severe illness. By preventing serious disease, vaccines may indirectly reduce the biological processes that contribute to tumour formation.

Medical specialists say the findings reinforce the value of preventing severe respiratory infections. Immunisation campaigns against both COVID-19 and influenza are designed primarily to reduce hospitalisations and deaths, yet the research suggests additional benefits related to long-term lung health. Preventing the most severe forms of illness may help protect the immune system from the lasting disruptions observed in the study.

The discovery also raises new questions about how respiratory disease should be monitored after recovery. Clinicians are increasingly studying the long-term effects of viral infections, including persistent respiratory symptoms, cardiovascular complications and neurological changes. Lung cancer risk now appears to be another area requiring careful investigation.

Researchers caution that the findings do not mean severe viral infections inevitably lead to cancer. Lung cancer remains influenced by many factors, including smoking, environmental exposure and genetic susceptibility. However, the study suggests that serious respiratory infections could represent an additional risk factor that interacts with these existing influences.

Scientists are continuing to examine how immune cells behave in lung tissue following viral illness. Advanced imaging techniques and genetic analysis are helping researchers trace how inflammation develops and persists after infection. Understanding these processes may lead to new treatments designed to restore healthy immune function and reduce cancer risk.

Public health authorities and cancer specialists are watching the research closely as they assess its implications for long-term disease prevention. Greater knowledge of how infections shape cancer risk may influence screening strategies, particularly for individuals who experienced severe respiratory illness requiring hospital care.